This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Upper Respiratory Tract Infections, Rhinopharyngitis, Sore Throat, Sinusitis, Otitis, Lower Respiratory Tract Infections, Bronchitis, Pneumopathy, Flu, Flu-like Syndromes or Gastroenteritis
and you are
between 18 and 29
years old
The phase for this study is not defined.
Show me locations

The purpose

This multicentric, randomized, double-blind and controlled study aims to examine the effect of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel® = tested product) on the incidence of respiratory and gastro-intestinal common infectious diseases (cumulated number of infections during the intervention period: primary criteria), and on the Quality of Life in adults submitted to multi-stressor situation. Volunteers received either 200g/day of tested product (N=121) or control product (N=118) for 7-weeks.

Provided treatments

  • Other: 1-Fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel®)
  • Other: 2-Non fermented dairy product (control)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01315418. The sponsor of the trial is Danone Research and it is looking for 239 volunteers for the current phase.
Official trial title:
Effect of the Consumption of a Fermented Milk on Common Infections in Adults Submitted to Multi-stressor Situation